Uploaded on Sep 16, 2026
The pharmaceutical industry is spending over $300 billion annually on R&D. Timelines are lengthening. Margins are narrowing. And 80 to 85% of clinical trials are still missing enrollment targets — at a cost of $800,000 for every day they run behind. More Info: https://clival.com/blog/why-clinical-trial-intelligence-is-critical-for-every-pharma-company
Why Clinical Trial Intelligence Matters
What Are You Missing in
Your Clinical Trial Data?
Why Clinical Trial Intelligence Matters
Better Data. Earlier Insights. Smarter Decisions.
The Intelligence Gap
The Data Exists.
But Is It Connected?
•Fragmented data
•Delayed insights
•Siloed teams
•Enrollment risks
•Missed signals
What Does It Connect?
One Trial Tells a Story.
Connected Data Tells More.
•Drug pipelines
•Trial data
•Regulatory signals
•PI & site intelligence
•Competitive activity
What Happens Without It?
What Could You Miss Without the Full Picture?
•Competitor moves
•Better trial sites
•Enrollment risks
•Licensing opportunities
•Critical signals
Who Uses It?
Different Teams.
One Intelligence Layer.
R&D → Trial & indication insights
BD & Licensing → Asset opportunities
Generic Pharma → Patent & ANDA insights
CROs → Sponsor & site intelligence
From Data to Decision
The Advantage Isn’t More Data.
It’s Getting the Right Insight Faster.
•Live data
•Automated monitoring
•Custom dashboards
•Competitive tracking
•Smarter workflows
Right Data → Right Time → Better Decisions
WEBSITE : WWW.CLIVAL.
COM
• WWW.LIFESCIENCEINTELLIPEDIA.COM
• WWW.CHEMXPERT.COM
LOCATION:- C-89, SECTOR-65 NOIDA-U.P. 201301
(INDIA)
E-MAIL:- [email protected] |
[email protected]
PHONE:- +91-120-6631301-335
MOB NO:- +91-9990237670
THANK YOU
Comments